PROCESS FOR PRODUCING SALICILATES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENT

摘要

Compounds of the general formula (I), wherein R is hydrogen, halogen, C1-4alkyl, C1-4alkoxy or a C1-4acylamino group; and R1 is hydrogen or a carboxyl-protective group, in the E and/or Z configuration, as well as their salts, show both a cytoprotective effect and anti-inflammatory action. Their toxicity is low.